Daniel Lang

Insider Reports History

Entity
Individual
Location
C/O Athenex, Inc. Conventus Building, 1001 Main St. Ste. 600, Buffalo, NY
Signature
/s/Steven Adams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Lang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Athenex, Inc. Pres Cell Therapy, VP Corp Dev Common Stock 81.6K $111K $1.36 Sep 16, 2022 Direct
Athenex, Inc. Pres Cell Therapy, VP Corp Dev Stock Option (Right to Buy) 200K Sep 16, 2022 Direct
Athenex, Inc. Pres Cell Therapy, VP Corp Dev Restricted Stock Units 37.5K Sep 16, 2022 Direct

Insider Reports Filed by Daniel Lang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATNXQ Athenex, Inc. Sep 16, 2022 3 -$1.77K 4 Sep 19, 2022 Pres Cell Therapy, VP Corp Dev
ATNXQ Athenex, Inc. Jul 20, 2022 1 $0 4 Jul 21, 2022 Pres Cell Therapy, VP Corp Dev
ATNXQ Athenex, Inc. Nov 22, 2021 0 $0 3 Dec 1, 2021 Pres Cell Therapy, VP Corp Dev